Company Filing History:
Years Active: 1996-2004
Title: The Innovations of Sarah L. Bolt
Introduction
Sarah L. Bolt is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of immunotherapy, particularly through her innovative work on antibodies. With a total of 2 patents, her research has the potential to impact therapeutic approaches in immunosuppression.
Latest Patents
Among her latest patents, Sarah has developed humanized anti-CD3 specific antibodies. These novel aglycosylated antibodies exhibit a binding affinity for the CD3 antigen complex, making them valuable for therapeutic use, especially in immunosuppression. Her work in this area showcases her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout her career, Sarah has worked with notable organizations, including British Technology Group Limited and BTG International Limited. Her experience in these companies has allowed her to collaborate with other experts in the field and further her research endeavors.
Collaborations
Sarah has collaborated with esteemed colleagues such as Michael Ronald Clark and Edward G. Routledge. These partnerships have enriched her work and contributed to the development of her innovative patents.
Conclusion
In summary, Sarah L. Bolt is a trailblazer in the field of immunotherapy, with her patents reflecting her dedication to advancing medical science. Her contributions are poised to make a lasting impact on therapeutic practices.